10000000146

22nd Century Group has been beaten down due to, in my opinion, a frivolous lawsuit filed last year, half of which has been thrown out of court, the other half being moved to a different court also in NY, but in my opinion, likely to be thrown out as well.

Numerous patents on nicotine reduction that no other company in tobacco can match and cannabinoids to the tune of over 200 patents and growing nationally and internationally.

They are already making money with sales over $10 million annually although they are mostly a research stage company. However, the list of clinical studies being done on their proprietary very low nicotine cigarettes by major universities and the National Institute of Health and other major medical entities that are showing how effective they are in reducing dependency on cigarettes and increasing the success of those who want to quit smoking is quite remarkable.

They have the right idea with their very low nicotine tobacco production increasing and they are wisely working with new and coming partners who are majors in the industry, since the tobacco is very high quality, just without the nicotine that addicts users.

They have a major disruptor in their very low nicotine cigarettes, and in their research cigarettes as well. Add to that that the FDA and the World Health Organization is calling for reduction of nicotine in cigarettes worldwide, and the reports from the FDA agencies working with XXII are on the fast track to approval. The science is not only in, it keeps coming in from university after university study. The volume of studies confirming XXII products is growing at an astounding rate. While in prior years the number of studies by NIH and major schools was under five, this year it's already near twenty ongoing studies. These are studies for the most part that are being done, being paid for, by the schools, by NIH, and not XXII, so are very very credible and very objective. They are looking at a wide range of issues in smoking cessation in these various, manifold studies.

If a person is pro-smoking, they will like the stock.
If a person is against smoking, they will like the stock.
If someone has lost someone to lung cancer, they will love it.
It's the way the tobacco industry has to go in the near and long term.

They have solid protection from all their patents.
At least one big tobacco company in invested in them.
They have a great hemp product with zero THC now gaining notice in industry circles of cannabis.

I will write an article elsewhere on MF. But this should suffice to raise interest to get you to do due diligence yourself from here.

Good luck.